Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/02/017387
CTRI/2019/02/017387
Not Yet Recruiting
N/A

Feasibility , safety and Clinical outcomes with a new design of hydrophobic capsular fixation IO

ethradhama Superspeciality Eye Hospital0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: H259- Unspecified age-related cataract

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: H259- Unspecified age-related cataract
Sponsor
ethradhama Superspeciality Eye Hospital
Status
Not Yet Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ethradhama Superspeciality Eye Hospital

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients with a cortical cataract or nuclear sclerosis (Senile Immature)
  • •2\.Ability to understand and willingness to sign informed consent
  • •3\.Willingness to participate in follow up visits

Exclusion Criteria

  • •1\.Patients having mature intumescent cataract
  • •2\.Subluxated lens with weak zonules
  • •3\.Cataract with pseudoexfoliation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
N/A
Evaluation of feasibility and clinical utility of computer assisted robotic devices for upper limb therapy for patients with cervical level spinal cord injuriesCervical level spinal cord injury
ACTRN12618001546246Tyromotion20
Recruiting
N/A
Clinical evaluation of PET probe [18F]SMBT-1Alzheimer's disease (AD), Progressive Supranulcear Palsy (PSP)
JPRN-jRCTs021200019Tashiro Manabu24
Completed
N/A
Exercise training in patients awaiting a liver transplantation: a randomised control trialiver TransplantExercise TrainingLiver TransplantPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitation
ACTRN12614000791639Mr Matthew Wallen21
Completed
N/A
Arm Intervention After Stroke (AIAS): a feasibility study
ISRCTN33421390HS Greater Glasgow and Clyde (UK)18
Recruiting
Phase 1
177Lu-edotreotide compared to everolimus in neuroendocrine tumors of the lung and thymusPatients with well to moderately differentiated neuroendocrine tumors of the lung and thymus who require systemic therapy.MedDRA version: 21.0Level: LLTClassification code: 10062476Term: Neuroendocrine tumor Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10078183Term: Neuroendocrine tumor of the lung Class: 10029104Therapeutic area: Diseases [C] - Neoplasms [C04]
CTIS2022-502154-13-00Grupo Espanol De Tumores Neuroendocrinos120